Trials / Conditions / Advanced Kidney Cancer
Advanced Kidney Cancer
5 registered clinical trials studyying Advanced Kidney Cancer — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | The Impact of Time-of-day-Dependent Administration of Nivolumab-Ipilimumab (ICI/ICI) Combination on Overall Su NCT07338981 | Guliz Ozgun | Phase 3 |
| Unknown | Tislelizumab Plus Lenvatinib in Stage III-IV RCC NCT05485883 | Tianjin Medical University Second Hospital | Phase 2 |
| Completed | Circulating and Urinary Exosomal miRNA in Advanced Kidney Cancer (EXO-RENAL1) NCT07406646 | Institute of Oncology Ljubljana | N/A |
| Withdrawn | Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer NCT03540199 | Fuda Cancer Hospital, Guangzhou | Phase 2 |
| Active Not Recruiting | Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer NCT03308396 | Ajjai Alva, MD | Phase 1 / Phase 2 |